• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Schering-Plough

Schering-Plough

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. OT and Telenor Group Partner to Be Ahead of the SIM Digitalization Era

    OT and Telenor Group Partner to Be Ahead of the SIM Digitalization Era

  2. Stockland Net Profit Edges Higher in First Half

    Stockland Net Profit Edges Higher in First Half

  3. Contrarian Buying at American Funds

    American's managers have been busy buying unloved large caps.

  4. This Pharma Firm Passes the Test

    Positive trial data for diabetes drug Januvia and strong first-quarter results keep Merck's stock undervalued and its wide moat intact.

  5. High-Priced Sale of Consumer Business Strengthens This Big Pharma Firm's Moat

    The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.

  6. Homestead Value

    With a rock-solid belief in their strategy, the managers of Homestead Value confidently go about their business.

  7. On the Muslim immigration ban, the law favors Trump

    On the Muslim immigration ban, the law favors Trump

  8. UPDATE: On the immigration ban, the law favors Trump

    UPDATE: On the immigration ban, the law favors Trump

  9. UPDATE: On the immigration ban, the law favors Trump

    UPDATE: On the immigration ban, the law favors Trump

123

©2017 Morningstar Advisor. All right reserved.